Death by a thousand cuts: the slow demise of chemotherapy

    loading  Checking for direct PDF access through Ovid

Abstract

Combining cytotoxic agents with novel agents is an inferior treatment option for patients with relapsed/refractory myeloma. Not all combination therapies have the same efficacy, and the agents in the combinations do matter. See also pages 2050–6.

Related Topics

    loading  Loading Related Articles